Strengthening clinical alliances between human and veterinary medicine to tackle global priority antimicrobial-resistant bacterial pathogens

  15 December 2025

This article discusses how antimicrobial resistance (AMR) is a growing global health threat affecting both humans and animals, with multidrug-resistant bacteria increasingly found across clinical settings in both sectors. While the One Health framework emphasizes collaboration between human and veterinary medicine to address AMR, its practical implementation in clinical practice remains limited. The authors highlight barriers to interprofessional collaboration—such as poor communication, ambiguity around One Health concepts, and lack of policies and training—and emphasize the need for stronger integration between physicians and veterinarians to share experiences and strategies. They argue that coordinated clinical alliances are essential to effectively confront shared antimicrobial-resistant pathogens and improve prescribing practices across species.

Author(s): Fábio Parra Sellera et al
Healthy Animals   Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!